S&P 500 Futures
(0.10%) 5 332.50 points

Dow Jones Futures
(0.07%) 40 164 points

Nasdaq Futures
(0.15%) 18 663 points

Oil
(0.30%) $80.30

Gas
(0.80%) $2.65

Gold
(1.13%) $2 444.60

Silver
(2.79%) $32.13

Platinum
(0.00%) $1 090.00

USD/EUR
(-0.01%) $0.920

USD/NOK
(-0.08%) $10.67

USD/GBP
(0.08%) $0.788

USD/RUB
(-0.26%) $90.73

Realtime updates for Oxurion NV [OXUR.BR]

Exchange: EURONEXT Industry: Biotechnology

Last Updated20 May 2024 @ 03:07

25% discount on Stockinvest.us - Use code: Podcast

-50.00% € 0.000100

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 03:07):

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction...

Stats
Today's Volume	1.78M
Average Volume	110.28M
Market Cap	1.01M
EPS	€0 ( 2024-04-05 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.0100
ATR14	€0 (0.00%)

Oxurion NV Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oxurion NV Financials

Annual	2023
Revenue:	€263 000
Gross Profit:	€104 000 (39.54 %)
EPS:	€-0.0115

FY	2023
Revenue:	€263 000
Gross Profit:	€104 000 (39.54 %)
EPS:	€-0.0115

FY	2022
Revenue:	€595 000
Gross Profit:	€-271 000 (-45.55 %)
EPS:	€-0.370

FY	2021
Revenue:	€1.13M
Gross Profit:	€516 000 (45.74 %)
EPS:	€-0.928

Financial Reports:

No articles found.

Oxurion NV Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Oxurion NV

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.